Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:308-318
Published online before print January 20, 2005, doi: 10.1161/01.RES.0000156273.30274.f7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/3/308    most recent
01.RES.0000156273.30274.f7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skurk, C.
Right arrow Articles by Walsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skurk, C.
Right arrow Articles by Walsh, K.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Angiogenesis
(Circulation Research. 2005;96:308.)
© 2005 American Heart Association, Inc.


Molecular Medicine

Glycogen-Synthase Kinase3ß/ß-Catenin Axis Promotes Angiogenesis Through Activation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells

Carsten Skurk, Henrike Maatz, Edward Rocnik, Ann Bialik, Thomas Force, Kenneth Walsh

From the Whitaker Cardiovascular Institute (C.S., H.M., E.R., A.B., K.W.), Boston University Medical Center, Boston, Mass; and the Department of Medicine (T.F.), Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, Mass.

Correspondence to Kenneth Walsh, PhD, Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St, W611, Boston, MA 02118. E-mail kxwalsh{at}bu.edu

Glycogen-Synthase Kinase 3ß (GSK3ß) has been shown to function as a nodal point of converging signaling pathways in endothelial cells to regulate vessel growth, but the signaling mechanisms downstream from GSK3ß have not been identified. Here, we show that ß-catenin is an important downstream target for GSK3ß action in angiogenesis and dissect the signal transduction pathways involved in the angiogenic phenotype. Transduction of human umbilical vein endothelial cells (HUVECs) with a kinase-mutant form of the enzyme (KM-GSK3ß) increased cytosolic ß-catenin levels, whereas constitutively active GSK3ß (S9A-GSK3ß) reduced ß-catenin levels. Lymphoid enhancer factor/T-cell factor promoter activity was upregulated by KM-GSK3ß and diminished by S9A-GSK3ß, whereas manipulation of Akt signaling had no effect on this parameter. ß-Catenin transduction induced capillary formation in a Matrigel-plug assay in vivo and promoted endothelial cell differentiation into network structures on Matrigel-coated plates in vitro. ß-Catenin activated the expression of vascular endothelial growth factor (VEGF)-A and VEGF-C in endothelial cells, and these effects were mediated at the levels of protein, mRNA, and promoter activity. Consistent with these data, ß-catenin increased the phosphorylation of the VEGF receptor 2 (VEGF-R2) and promoted its association with PI3-kinase, leading to a dose-dependent activation of the serine–threonine kinase Akt. Inhibition of PI3-kinase or Akt signaling led to a significant reduction in the pro-angiogenic activity of ß-catenin. Collectively, these data show that the growth factor–PI3-kinase–Akt axis functions downstream of GSK3ß/ß-catenin signaling in endothelial cells to promote angiogenesis.


Key Words: ß-catenin • Akt • endothelial cells • vacular endothelial growth factor • VEGF receptor 2 • angiogenesis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. M.L. Beckers, J. J. Garcia-Vallejo, V. W.M. van Hinsbergh, and G. P. van Nieuw Amerongen
Nuclear targeting of {beta}-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction
Cardiovasc Res, June 2, 2008; (2008) cvn127v2.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. B. Joshi, D. Ivanov, M. Philippova, P. Erne, and T. J. Resink
Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells
FASEB J, October 1, 2007; 21(12): 3083 - 3095.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M.-C. Hsu, H.-C. Chang, and W.-C. Hung
HER-2/neu transcriptionally activates Jab1 expression via the AKT/{beta}-catenin pathway in breast cancer cells
Endocr. Relat. Cancer, September 1, 2007; 14(3): 655 - 667.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. S. Barbieri and B. B. Weksler
Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo
FASEB J, June 1, 2007; 21(8): 1831 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, J. B. Gilner, V. L. Bautch, D.-Z. Wang, B. J. Wainwright, S. L. Kirby, and C. Patterson
Wnt2 Coordinates the Commitment of Mesoderm to Hematopoietic, Endothelial, and Cardiac Lineages in Embryoid Bodies
J. Biol. Chem., January 5, 2007; 282(1): 782 - 791.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
I. Shiojima and K. Walsh
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Genes & Dev., December 15, 2006; 20(24): 3347 - 3365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Leung, Y. L. Pon, R. N. S. Wong, and A. S. T. Wong
Ginsenoside-Rg1 Induces Vascular Endothelial Growth Factor Expression through the Glucocorticoid Receptor-related Phosphatidylinositol 3-Kinase/Akt and beta-Catenin/T-cell Factor-dependent Pathway in Human Endothelial Cells
J. Biol. Chem., November 24, 2006; 281(47): 36280 - 36288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Y. Hahn, H.-J. Cho, J.-W. Bae, H.-S. Yuk, K.-i. Kim, K.-W. Park, B.-K. Koo, I.-H. Chae, C.-S. Shin, B.-H. Oh, et al.
beta-Catenin Overexpression Reduces Myocardial Infarct Size through Differential Effects on Cardiomyocytes and Cardiac Fibroblasts
J. Biol. Chem., October 13, 2006; 281(41): 30979 - 30989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. W. Arvisais, A. Romanelli, X. Hou, and J. S. Davis
AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2{alpha}
J. Biol. Chem., September 15, 2006; 281(37): 26904 - 26913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. F. Rocnik, P. Liu, K. Sato, K. Walsh, and C. Vaziri
The Novel SPARC Family Member SMOC-2 Potentiates Angiogenic Growth Factor Activity
J. Biol. Chem., August 11, 2006; 281(32): 22855 - 22864.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Liebner, U. Cavallaro, and E. Dejana
The Multiple Languages of Endothelial Cell-to-Cell Communication
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1431 - 1438.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
T. N. H. Masckauchan and J. Kitajewski
Wnt/Frizzled Signaling in the Vasculature: New Angiogenic Factors in Sight
Physiology, June 1, 2006; 21(3): 181 - 188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Izumi, S. Kim-Mitsuyama, M. Yoshiyama, T. Omura, M. Shiota, A. Matsuzawa, T. Yukimura, T. Murohara, M. Takeya, H. Ichijo, et al.
Important Role of Apoptosis Signal-Regulating Kinase 1 in Ischemia-Induced Angiogenesis
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1877 - 1883.
[Abstract] [Full Text] [PDF]